Laura Franshaw
Cancer Institute of New South Wales(AU)UNSW Sydney(AU)
Publications by Year
Research Areas
Glioma Diagnosis and Treatment, Histone Deacetylase Inhibitors Research, Protein Degradation and Inhibitors, Epigenetics and DNA Methylation, Cancer, Hypoxia, and Metabolism
Most-Cited Works
- → Dual targeting of mitochondrial function and mTOR pathway as a therapeutic strategy for diffuse intrinsic pontine glioma(2018)88 cited
- → Dual targeting of the epigenome via FACT complex and histone deacetylase is a potent treatment strategy for DIPG(2021)41 cited
- → International experience in the development of patient-derived xenograft models of diffuse intrinsic pontine glioma(2018)39 cited
- → Integration of genomics, high throughput drug screening, and personalized xenograft models as a novel precision medicine paradigm for high risk pediatric cancer(2018)25 cited
- → Predictors of Success of Phase II Pediatric Oncology Clinical Trials(2019)9 cited
- → Correction to: International experience in the development of patient-derived xenograft models of diffuse intrinsic pontine glioma(2018)4 cited
- → DIPG-07. HIGH THROUGHPUT DRUG SCREENING IDENTIFIES POTENTIAL NEW THERAPIES FOR DIFFUSE INTRINSIC PONTINE GLIOMAS (DIPGs)(2020)2 cited
- → Abstract 1561: Preclinical examination of PLK1 inhibitors for the treatment of diffuse midline gliomas(2023)2 cited
- → RARE-08. POTENTIAL NEW THERAPIES FOR DIFFUSE INTRINSIC PONTINE GLIOMAS IDENTIFIED THROUGH HIGH THROUGHPUT DRUG SCREENING(2021)2 cited
- → Translating palbociclib to the clinic for DIPG - What is truly achievable?(2019)2 cited